Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Stefanie, Pederiva"'
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 1, Pp 365-370 (2021)
Small-cell carcinoma of the pancreas (PSCC) is a highly aggressive neoplasia with a dismal prognosis. It is extremely rare, with only a few cases reported in the literature. There is a paucity of clinical data to guide management and since the diseas
Externí odkaz:
https://doaj.org/article/c7067c0eaa5d479d858b3f01245c750c
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 14, Iss 1, Pp 365-370 (2021)
Case Reports in Oncology, Vol 14, Iss 1, Pp 365-370 (2021)
Small-cell carcinoma of the pancreas (PSCC) is a highly aggressive neoplasia with a dismal prognosis. It is extremely rare, with only a few cases reported in the literature. There is a paucity of clinical data to guide management and since the diseas
Autor:
Ralf-Dieter Hofheinz, Sandro Anchisi, Birgit Grünberger, Hans G. Derigs, Mark-Oliver Zahn, Christine Geffriaud-Ricouard, Max Gueldner, Christine Windemuth-Kieselbach, Stefanie Pederiva, Pierre Bohanes, Felicitas Scholten, Gudrun Piringer, Josef Thaler, Roger von Moos
Publikováno v:
Cancers; Volume 14; Issue 14; Pages: 3522
Aflibercept plus FOLFIRI prolongs overall survival (OS) in patients with metastatic colorectal cancer after the failure of oxaliplatin-containing therapy. QoLiTrap prospectively evaluated the quality of life (QoL) and effectiveness of this regimen in
Publikováno v:
Forum Médical Suisse ‒ Swiss Medical Forum.
Publikováno v:
Swiss Medical Forum ‒ Schweizerisches Medizin-Forum.
Autor:
Davide Rossi, Rahel Schwotzer, Raphael Heimgartner, Andreas J. Flammer, Georg Stussi, Bernhard Gerber, Guido Ghilardi, Erika Lerch, Christine Waibel, Harald Seeger, Clemens Caspar, Stefanie Pederiva, Thomas Fehr, Elena Bianchi, Markus G. Manz, Sofie Brouwers
Publikováno v:
Hematological Oncology. 37:595-600
Daratumumab, an anti-CD38 antibody, is effective in AL amyloidosis with low tumor burden. Data of daratumumab treatment in patients with AL amyloidosis but high tumor burden (≥10% bone marrow plasma cells) are limited. We report retrospective data
Autor:
Sandro Anchisi, Vera Bühler, Daniel Betticher, Stefanie Pederiva, Roger von Moos, Regina Woelky, Miklos Pless, Marco Dressler, Sacha I. Rothschild, Peter Moosmann, Reinhard Zenhäusern, R. A. Popescu, Markus Borner, Daniel Rauch, Claudia Papet, Antonello Calderoni
Publikováno v:
Rothschild, Sacha I; Betticher, Daniel; Zenhäusern, Reinhard; Anchisi, Sandro; von Moos, Roger; Pless, Miklos; Moosmann, Peter; Popescu, Razvan A; Calderoni, Antonello; Dressler, Marco; Rauch, Daniel; Pederiva, Stefanie; Woelky, Regina; Papet, Claudia; Bühler, Vera; Borner, Markus (2019). Prospective, observational practice survey of applied skin care and management of cetuximab-related skin reactions: PROSKIN study. Cancer chemotherapy and pharmacology, 84(4), pp. 881-889. Springer 10.1007/s00280-019-03927-x
Cancer Chemotherapy and Pharmacology
Cancer Chemotherapy and Pharmacology
PURPOSE The study aimed to investigate strategies to prevent and treat cetuximab-induced skin reactions and their perceived effectiveness in patients with metastatic colorectal cancer (mCRC) and recurrent/metastatic squamous cell cancer of the head a
Autor:
M-O. Zahn, Josef Thaler, Christine Windemuth-Kieselbach, Gudrun Piringer, Sandro Anchisi, F. Scholten, R.D. Hofheinz, R. von Moos, B. Grünberger, Pierre Oliver Bohanes, Stefanie Pederiva, H. Kröning, H.-G. Derigs
Publikováno v:
Annals of Oncology. 32:S574-S575
Autor:
Alexander Siebenhüner, Daniel Helbling, Christoforos Astaras, Petr Szturz, Stefanie Pederiva, Peter Moosmann, Sara De Dosso, Markus Borner, Philippe Von Burg, Thomas Winder
Publikováno v:
Oncology research and treatment. 44(9)
Background: Gastric cancer is a leading cause of cancer-related deaths worldwide. Several treatment possibilities have been investigated, but only a few show clinically meaningful results. Summary: Systemic treatment options for advanced gastric canc
Autor:
Ulrich J. M. Mey, Felicitas Hitz, Andreas Lohri, Stefanie Pederiva, Christian Taverna, Alexander Tzankov, Oliver Meier, Karen Yeow, Christoph Renner
Publikováno v:
Swiss Medical Weekly, Vol 142, Iss 0506 (2012)
Diffuse large B-cell lymphoma (DLBCL) is the most frequently-occurring type of malignant lymphoma in the Western world. It has an aggressive natural history, with a median survival of less than one year if left untreated. Immunochemotherapy regimens,
Externí odkaz:
https://doaj.org/article/60c2c513282e46599040739cecb8864b